ROS facilitate carcinogenesis by reversibly inhibiting certain tumor suppressors, such as phosphatase and tensin homolog (PTEN) and protein tyrosine phosphatases (PTPs), which enhance antioxidant expression and thus decrease ROS levels. This evidence concerns the gene PTEN and neoplasm.